Time since SARS-CoV-2 infection and humoral immune response following BNT162b2 mRNA vaccination

BACKGROUND: To optimise the use of available SARS-CoV-2 vaccines, some advocate delaying second vaccination for individuals infected within six months. We studied whether post-vaccination immune response is equally potent in individuals infected over six months prior to vaccination. METHODS: We test...

Descripción completa

Detalles Bibliográficos
Autores principales: Appelman, Brent, van der Straten, Karlijn, Lavell, A.H. Ayesha, Schinkel, Michiel, Slim, Marleen A., Poniman, Meliawati, Burger, Judith A., Oomen, Melissa, Tejjani, Khadija, Vlaar, Alexander P.J., Wiersinga, W. Joost, Smulders, Yvo M., van Vught, Lonneke A., Sanders, Rogier W., van Gils, Marit J., Bomers, Marije K., Sikkens, Jonne J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2021
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8461365/
https://www.ncbi.nlm.nih.gov/pubmed/34571363
http://dx.doi.org/10.1016/j.ebiom.2021.103589

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8461365/
https://www.ncbi.nlm.nih.gov/pubmed/34571363
http://dx.doi.org/10.1016/j.ebiom.2021.103589

Ejemplares similares